PRCT
PROCEPT BioRobotics is a medical device company focused on advancing urology through robotic-assisted treatments, notably Aquablation therapy for benign prostatic hyperplasia. The company develops and promotes ultrasound-guided, waterjet-based robotic systems such as AquaBeam and HYDROS to assist surgeons in achieving precise prostate tissue removal. With patient care and surgeon empowerment as core goals, PROCEPT BioRobotics emphasizes evidence from clinical data and a global reach across healthcare providers and markets.
No recent news for this company.
No recent deals for this company.